Stock listing

NASDAQ:STML Stemline Therapeutics Inc Stock

Follow Stemline Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:STML

$11.83 USD

Close on Jun 11, 2020 · No longer trades

Jan 28, 2013 to last close +18.3% · weekly closes, Jan 28, 2013 – Jun 11, 2020
Lowest – highest close
$3.41 – $47.13 USDSince Jan 28, 2013 · lowest Mar 18, 2020 · highest Oct 1, 2013

Delisted NASDAQ:STML no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:STML
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Stemline Therapeutics Inc on 6ix

Decks
2 decks · latest Dec 13, 2017

Decks

DeckKindSlidesDate
Analyst and Investor Meeting, ASH 2017Conference41 slidesDec 13, 2017
IPO Roadshow (May 2013)IPO roadshow33 slidesMay 7, 2013

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Kenneth Hoberman
Other companies: Nuvectis Pharma, Inc. (Director · Since at least Feb 8, 2022); TG Therapeutics, Inc. (Chief Operating Officer and Corporate Secretary · Since at least Jun 26, 2018)
Chief Operating Officer · Dec 15, 2017 – Jun 10, 2020 · Past
Ron Bentsur
Other companies: Nuvectis Pharma, Inc. (Chairman & CEO, Director · Since at least Feb 4, 2022); Beyond Air, Inc. (Director · Jul 27, 2020 – Nov 22, 2024 · Past)
Director · Jun 25, 2019 – Jun 10, 2020 · Past
Alan S Forman
Other companies: JBG Smith Properties (Director · Since at least May 2, 2019)
Director · Jun 25, 2019 – Jun 10, 2020 · Past
David Gionco
Other companies: Savient Pharmaceuticals Inc (Chief Accounting Officer · Feb 12, 2009 – Oct 15, 2013 · Past)
Chief Accounting Officer · Jan 16, 2014 – Jun 10, 2020 · Past
Robert Francomano
Other companies: SELLAS Life Sciences Group, Inc. (Chief Commercial Officer · Mar 14, 2022 – Jan 22, 2024 · Past)
Chief Commercial Officer · Dec 6, 2019 – Jun 10, 2020 · Past

Open People

Log in to ask 6ix AI your own questions about Stemline Therapeutics Inc.